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There is evidence that normal lymphoid cells synthesize and accumulate immuno- 
globulin structures on their surface (1, 2). Much of the evidence is provided by experi- 
ments in which anfi-immunoglobulin  antibodies were found to react with the cell sur- 
face. By these studies antigenic structures of the various parts of serum immunoglobu- 
lin molecules have been detected on lymphoid cells. There is, however,  scanty addi- 
tional information on the relationship between the surface structures and serum irn- 
munoglobulin  and how the former are incorporated and kept in the surface membrane. 
Recently, it has been found that cells from some Burkitt tumors (3-5) and chronic 
lymphocytic leukemias (1, 6)  have IgM  1 heavy chain (mu chain)  and kappa  light 
chain structures on the surface in sufficient  amounts to be demonstrated by fluores- 
cein-labeled antibodies in fuorescence microscopy. The intracellular amounts of irn- 
munoglobulins  were apparently very small. Mu and kappa structures have also been 
demonstrated on normal cells by the same technique (1, 7, 8). 
The major fraction of IgM in human serum has a sedimentation  coefficient of about 
19S and the molecules consist of five subunits (9) bound together by disulfide bonds. 
The subunits have a sedimentation  coefficient of about 7S and are composed of two mu 
and two light chains linked together by disulfide  as well as noncovalent bonds. A 
minor fraction of IgM in normal serum is similar in size to 7S IgM (10,  11). In cells 
engaged in 19S IgM secretion, 7S IgM and only small amounts of 19S IgM were found 
(12). 
In order  to  learn more  about surface immunoglobulin structures,  the  leu- 
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kemia cells from one of the patients mentioned above have been studied. Mu  and 
kappa  structures have been released  and their size determined.  A  preliminary 
report has been presented elsewhere  (13). 
Material and Methods 
Human  19S IgM.--IgM with kappa chains was purified in large scale from the sera of 
patients  with  Waldenstr6m's  macroglobulinemia  by  zone  electrophoresis  using  Pevikon 
(Kema Nord, Stockholm, Sweden) as supporting medium  (14), followed by gel  filtration on 
Sephadex G-200 (Pharmacia Fine Chemicals, Uppsala, Sweden). 
Human  7S IgM.--By reduction of purified 19S IgM with 0.2 •  2-mercaptoethanol, fol- 
lowed by alkylation with iodoacetamide, 7S IglY[ was obtained (15). The material was finally 
passed through Sephadex G-200 to ascertain that only 7S IgM was present. 
Human  Kappa  Chalns.--Kappa  chains were isolated by chromatography of the 7S IgM 
on a Sephadex G-100 column equilibrated with 1 N propionic acid (16). 
Human IgG.--A solution of Kabi gamma globulin 16.5% (Kabi, Stockholm, Sweden) was 
used. 
By double diffusion in gel and immunoelectrophoresis antibodies against transferrin, IgM, 
IgG, kappa chains, lambda chains, a2-macroglobulin, and human serum proteins revealed no 
impurities in the IgM (4 mg/ml) and kappa chain (0.5 mg/ml) preparations. 
Rabbit 7S  Gamma Globulin.--Rabbit  gamma globulins, more than 98% pure on electro- 
phoresis (Mann Research Laboratories Inc., New York) were used. The protein was passed 
through a Sephadex G-200 column. Two smaller protein peaks emerged first, then a large peak. 
The latter peak had the position in the elution diagram characteristic for human 7S gamma 
globulin. Fractions from this peak were pooled, concentrated to 7 mg/ml, and labeled with 
125I using an electrolytic method (17). 
After determination of the labeling efficiency (15),  the solution was dialyzed in order to 
remove free iodine.  As a  final purification step  the protein solution was run in  the ultra- 
centrifuge on a sucrose density gradient. In experiments to be described, only material from 
the 7S peak was used. 
The labeling efficiency was 84%, mean iodine content 0.8 moles/mole of protein. 
Antisera.--Rabbit  immunoglobulin  preparations  from  Dakopatts  A/S,  delivered  by 
Brostex  A/S,  Copenhagen,  Denmark,  against  human  serum  proteins,  IgG,  IgM,  kappa 
chains, and  lambda  chains, were used.  Rabbit antisera against transferrin and  o~2-macro- 
globulin were supplied by Behringwerke AG, Marburg-Lahn, Germany. 
The  reagents were  tested against the protein preparations described above and  normal 
human serum by immunoelectrophoresis and double diffusion in gel. As the anti-IgM reagent 
reacted with IgM, but not with IgG or free kappa chains, this reagent will be designated anti- 
mu reagent or anti-mu antibodies. 
For fluorescence microscopy, fluorescein-labeled goat globulins from Hyland Laboratories, 
Los Angeles, Calif., against human kappa chains and IgM were used. The latter reagent will 
also be designated anti-mu reagent or anti-mu antibodies. The reactivity could not be blocked 
by free kappa chains. For the detection of human HL-A  transplantation antigens, fluores- 
cein-conjugated globulins from the serum of  a  patient  (Berlin)  who had  obtained multiple 
transfusions was used. The serum was received from Dr. Dausset. 
Protein Determinations.--Protein determinations were made by a modified Folin technique 
(18) or by optical density at 280 nm. The standard curves were obtained with samples from 
Kabi's 16.5% gamma globulin solution. The protein content was assumed to be 165 mg/ml. 
Gel  Diffusion  Techniques.--The  Ouchterlony  technique  was  used  for  double  diffusion, 
employing 1% agarose in 0.11  ~  Na-barbital-HC1 buffer, pH 8.6.  The weUs were 3 ram in T.  ESKELAND,  E.  KLEIN,  M.  INOITE, AND  B.  ~OI-IANSSON  267 
diameter, with a center-to-center  distance of 7 mm. Immunoelectrophoresis  was performed by 
the technique of Wadsworth and Hanson (19). 
Leukemia  Cells.--Leukemia cells with mu and kappa structures on the cell surface were 
obtained from the blood of T. P., an 82 yr old male with chronic lymphocytic leukemia. His 
case report  (6)  and a  study of the immunoglobulin structures on the cell surface (1)  have 
recently been published. In the electron microscope, the ceils were similar to lymphoblasts 
(20). At the time of this study the leukocyte count in the peripheral blood was about 400,000 
per mm 3, most of the cells being small lymphocytes. 
For the purification of white blood cells,  fresh blood  (with citrate added)  was used.  3 
volumes of blood were mixed with 1 volume of 3% dextran T-250  (Pharmacia Fine Chemicals) 
in 0.15 •  NaC1. The suspension was incubated at 37°C for half an hour. Mter incubation, the 
upper layer with mostly leukemia cells was removed and the cells were washed one to two 
times in Hanks' balanced salt solution (BSS) 2 containing 1% gelatin (BSSg). About 1 ml of 
packed cells with a concentration of about 2.5 X  109 leukocytes/ml was usually obtained from 
10  ml of blood. In order to lyse the remaining erythrocytes, a  solution containing 0.14 
NH4C1 and 0.01 ~t ethylenediaminetetraacetate (EDTA) was added (21). The suspension was 
placed at 4°C for 10 min; the leukocytes were then sedimented by centrifugation at low speed. 
The treatment was repeated once if some erythroctyes were still intact. The purified leuko- 
cytes were washed three times in BSSg and finally once in BSS. Most of the leukocytes were 
still viable after this procedure, as judged from their ability to exclude trypan blue. 
In the later stages of this study the erythrocytes were removed by NH4Cl-lysis only. The 
yield of lenkocytes increased somewhat wiht this treatment. 
Homogenization and SubceUular Fractionation.--The procedures were performed at 0-5°C. 
Usually 9  ml of a  solution  containing 0.033  M tris(hydroxymethyl)aminomethane (Tris)- 
HC1, pH 8.0, and 0.005 M MgC12 was added to 1 ml of viable or frozen and thawed cells. The 
suspension was homogenized in a Potter-Elvehjem homogenizer run at 1800 rpm. The pestle 
diameter was 2.4 cm. The homogenization was finished when most of the nuclei seemed to be 
free of cytoplasm as examined by phase contrast microscopy, usually after 50 strokes. The 
homogenate was then centrifuged at a speed sufficient  to sediment nuclei and unbroken cells, 
that was about 2000 ga for 10 min. The precipitate was designated Prec. la, the supernatant 
Sup.  la. Tris buffer was added to Prec. la in the original volue, and the homogenization and 
centrifugation was repeated. Sup. lb and Prec. lb were then obtained (Fig. 3). 
For the sedimentation of all cellular particles (22), Sup. la and Sup.  lb were subjected to 
ultracentrifugation in a Spinco type 65 fixed angle rotor for 2 hr at 35,000 rpm giving about 
105,000 g. The superuatants, called Sup.  2a and Sup. 2b, were then removed, while Prec. 2a 
was suspended in Tris buffer in the original volume and subjected to 50 strokes in the Potter- 
Elvehjem homogenizer. After homogenization, the solution was subjected to ultracentrifuga- 
tiou at 105,000 g for 2 hr. Prec. 2a was thus divided in Sup. 2c and Prec. 2c (Fig. 3). Finally, 
Sup. 2a,  Sup.  2b, and Sup. 2c were concentrated about 10 times by vacuum dialysis using a 
Collodion filter No.  13200 (Sartorius-Membranfilter GmbH,  GSttingen, West Germany). 
Initially, the sedimentation of material in Sup.  la was performed by running at 5000 g for 
15 min, followed by runs for 30 min each at 5000, 10,000, 20,000, 40,000, and 80,000 g. After 
each run, the precipitate was dissolved in a small volume of Tris buffer, while the supernatant 
was subjected to further centrifugation. 
For quantitation of mu and kappa structures (see below), small samples were taken from 
2 Abbreviations used in this paper: BSS, Hanks' balanced salt solution; BSSg, BSS contain- 
ing 1% gelatin; FS, fluorescence  staining; PBS, phosphate-buffered saline,  PBSg, PBS  con- 
taining 0.1% gelatin; PHA, passive hemagglutination. 
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the solution of frozen and thawed cells, homogenate, supernatants, and precipitates. With the 
exception mentioned above, the samples from the precipitates were taken after the precipi- 
tates had been resuspended to the original volume and homogenized. 
Extraction by Washing of Frozen and  Thawed Cdls.--Cells  frozen and thawed once were 
suspended in BSSg to a 20% solution and kept on ice for 15 min. The cells were then sedi- 
mented at 2000 g for 10 rain.  The precipitate was resuspended in the original volume and the 
treatment repeated. After centrifugation, the precipitate was dissolved in Tris buffer in the 
original  volume  and  homogenized in  a  Potter-Elvehjem  homogenizer  as  described.  The 
solution was then run at 2000 g for 10 min. Finally, the three supernatants were run at 105,000 
g for 2 hr and the mu and kappa structures quantitated. 
Mercaptoethanol Extraction.--To  1 ml of packed viable ceils was added  1.5  ml 0.1  M 2- 
mercaptoethanol in 0.1 •  Tris-HCi buffer, pH 7.2. After 1 hr at 37°C with agitation, the super- 
natant obtained after sedimentation at 800 g for 10 rain was removed and the treatment re- 
peated once. The two supernatants were pooled and dialyzed against 120 ml 0.4 ~ iodoaceta- 
mide in 0.1  ~  Tris-HC1  buffer, pH 7.2. The supernatant was then fractionated by adding 
solid  (NH4)2SO4. The precipitate formed between 15  and 40%  saturation was sedimented, 
dissolved in 0.4 ml 0.1 M Tris-HCl buffer, pH 7.2, and dialyzed against BSS. Mu and kappa 
structures were assayed in the final solution. 
Density Gradient Ultracentrifugatlon.--The centrifugation was performed by using 4.4 ml of 
a 40-10% sucrose gradient in 0.07 M Tris-HC1 buffer, pH 8.0, and a Spinco swinging bucket- 
type SW 65 rotor at 5°C for 17 hr at 36,000 rpm giving about 140,000 g. 
Gel Filtration.--After  concentration Sup. 2a was filtrated on a 1 X  100 cm Sephadex G-200 
column, equilibrated with a solution containing 0.3 ~ NaC1, 0.01 M boric acid-NaOH, pH 8.0, 
and 0.02% NAN3. The flow rate was approximately 2 ml/hr. 
Inhibition of Passive Hemagglutination.--For detection and quantitation of mu and kappa 
structures in the various cellular fractions inhibition of passive bemagglutination was per- 
formed. 
IgM-coated cells were prepared as follows: to a 3% solution of formallnized sheep red blood 
cells in 0.135 M NaC1 and 0.01 M phosphate buffer, pH 7.0 (PBS), was added an equal volume 
of a  0.005%  solution of tannic acid  (E.  Merck AG, Darmstadt, West  Germany)  and  the 
suspension was incubated at 37°C for 10 min. After washing three times with PBS and re- 
suspending the cells in the original volume, an equal volume of PBS containing 0.5 mg 19S 
IgM/ml was added, and the suspension was incubated for 15 rain at 37°C. The cells were then 
washed three times with PB  S containing 0.1% gelatin (PB Sg), and were finally resuspended in 
PBSg in the double of the original volume. 
The inhibition tests were performed in disposable plastic trays (Linbro Chemical Co., New 
Haven, Connecticut, model MVC-96 with V-shaped 0.3 ml volume cups). 1 drop of anti-mu 
reagent diluted 1/~000 to ~000  with PBSg, or 1 drop of anti-kappa reagent diluted ~00  to 
1~00 , and 1 drop of PBSg was added to 1 drop of undiluted or doubling dilutions of test ma- 
terial. After incubation for 45  rain at 37°C,  1 drop of the solution of IgM-coated cells was 
added, and the incubation continued for 45 min. The trays were then placed at room tem- 
perature and read the next morning. In the cases where the test material contained particulate 
material, equal volumes of the test material, PBSg, and antibody reagent were added to small 
centrifuge tubes. Mter incubation, the tubes were run at 2200 g for 15 min, and three drops of 
the supernatants from each tube transferred to the trays. The procedure was then continued 
as described above. 
By comparison of the inhibition efficiency of the test material in serial dilutions and known 
amounts of IgM or kappa chains, the amounts of mu and kappa structures were quantitated. 
In these quantitations only cups with complete inhibition were counted. 
The dilution of anti-mu and anti-kappa reagents were the highest dilutions giving complete 
agglutination of the test cells when no inhibitory material was present. 
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fluorescein-labeled anti-HL-A, anti-mu, or anti-kappa reagents was also assayed in some in- 
stances. The antibody reagents were incubated with test material before the leukemia cells 
were added  (for details see reference 1).  At least two antibody dilutions were used  and  se- 
lected as the highest dilutions giving  bright staining of the cells  in the absence of  inhibitory ma- 
terial. Comparable results were usually obtained with this method and with inhibition of 
passive hemagglutination. 
RESULTS 
Liberation of Mu and Kappa Structures from the Cells by Homogenization.- 
After homogenization of viable or frozen and thawed cells, the homogenate was 
exposed to 2000 g for 10 rain. The supernatant (Sup. la) which was free of nuclei 
and unbroken cells was found to contain mu and kappa structures by using in- 
hibition of passive hemagglutination or fluorescence staining. The supernatant 
also inhibited the staining of viable leukemia cells with fluorescein-conjugated 
antibodies against HL-A antigens, showing that mu and kappa structures were 
not the only membrane structures liberated. 
The size  of the immunoglobulin structures  in  Sup.  la was investigated by 
differential centrifugation as shown in Table I. Although the efficiency of the 
various fractions in inhibiting anti-mu antibodies in passive hemagglutination 
and fluorescence staining did not correspond exactly, there seems to be an in- 
creasing sedimentation of mu and HL-A antigens as the g value increased. But 
even 80,000 g for 30 min left mu structures in the supernatant. 
Since the membrane fragments carrying mu structures were sedimented at a 
broad range of g values, the centrifugation of the homogenate was simplified to 
include a run at 2000 g for 10 min, followed by an ultracentrifugation at 105,000 
g for 2 hr. The ultracentrifugation is supposed to sediment all membranes, but 
the supernatant,  Sup.  2a,  still  contained mu and kappa structures  as judged 
from its ability to inhibit the corresponding antibodies in passive hemagglutina- 
tion and fluorescence staining. 
Determination of the Size of the Free Immunoglobulin Structures.--For  analysis 
of the size of the immunoglobulin structures in Sup. 2a, it was concentrated and 
a  small  amount of rabbit  7S gamma globulin labeled  with 1~5I was  added  as 
marker  substance.  Sephadex  G-200 filtration  and  density  gradient  ultracen- 
trifugation were then performed. For comparison, 5/~1 of normal human serum 
to which was added 125I-labeled rabbit  gamma globulin was run in  a  parallel 
tube in the ultracentrifuge. The fractions obtained were tested for mu and kappa 
structures by inhibition of passive hemagglutination. It was found that the mu 
and some of the kappa structures sedimented in a  similar manner to 7S rabbit 
gamma globulin (Fig. 1) and were eluted from the gel in the same fractions (Fig. 
2), while some of the kappa structures were apparently of smaller size. The most 
likely interpretation seems to be that the mu structures and some of the kappa 
structures are chains forming 7S IgM molecules, while some of the kappa struc- 
tures occur as free kappa chains. 
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tities of mu and kappa structures  in the various fractions shown by Fig. 3 were 
compared by their ability to inhibit passive hemagglutination with anti-mu and 
anti-kappa antibodies. 
The  inhibitory  efficiency  of  the  fractions  was  compared  to  that  of  known 
amounts  of IgM  and kappa  chains.  I9S IgM  and 7S IgM  were found to have 
TABLE I 
Anti-HL-A FS  Anti-mu FS  Anti-mu PHA 
2000 g  Prec. la 
10 min  Sup. la  --  --  -- (1/4) 
5000 g  Prec.  --  --  + ? 
15 min  Sup.  _  _  _  (1~) 
5000 g  Prec.  --  --  + ? 
30 min  Sup.  +  +  --  -- (~) 
10,000 g  Prec.  --  --  + ? 
30 min  Sup.  +  +-  -- (~) 
20,000 g 
30 min  Prec.  +  +-  -- 
40,000 g  Sup.  +  +  --  -- (~) 
30 min 
80,000 g  Prec.  +  +  --  -- 
30 min  Sup.  +_  +  _  (1/~) 
Inhibition of the reactivity of anti-mu antibodies in passive hemagglutination  (anti-mu, 
PHA)  and  in fluorescence  staining  (anti-mu, FS), and  of anti-HL-A antibodies in fluores- 
cence staining (anti-HL-A, FS) by various cellular fractions is shown.  Before testing a small 
volume of Tris buffer was added  to the precipitates. 
-- Inhibition. The numbers in parentheses show the highest dilution giving inhibition. 
+-  Very weak, if any inhibition. 
+  No inhibition. 
+? No inhibition, probably due to large particles in the precipitates. 
similar inhibiting power on a weight basis of anti-mu and anti-kappa antibodies, 
and for convenience 19S IgM was used as reference. The inhibition of anti-kappa 
antibodies by known  amounts of kappa  chains  and  IgM  is  shown in Table II, 
right.  By assuming  a  molecular weight  of 22,500  for kappa  chains  and  67,500 
for mu chains  (9),  it was calculated that  free kappa  chains have less inhibiting 
power than  kappa  chains in IgM. 
The results of one quantitation  experiment are presented in Table II. Similar 
results were obtained in several experiments. The left part of Table II shows that 
the same amounts of mu structures were found in whole cells (frozen and thawed) 
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contained most of the mu structures found in whole cells. Rehomogenizafion of 
the precipitate (Prec. la) liberated only small amounts of mu structures. After 
ultracentrifugation of Sup.  la,  the precipitate (Prec. 2a)  and the supernatant 
(Sup.  2a)  contained  approximately  equal  amounts  of mu structures.  Reho- 
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FIG.  1.  Sucrose density gradient nltracentrifugation of Sup. 2a after concentration (left) 
and normal human serum (right). 12aI-labeled  7S rabbit gamma globulin was added to both 
samples. The bottom fraction is fraction No. 1. The open circles show the amount of 7S rabbit 
gamma globulin expressed as counts per second. Kappa and mu structures were localized by 
inhibition of passive hemagglutination. Small filled circles (*), weak inhibition; large filled 
circles (O), strong inhibition. 
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FIG,  2.  Sephadex G-200 filtration of msIqabeled 7S rabbit gamma globulin and Sup. 2a 
after concentration. Each fraction contained approximately 0.5 ml. Void volume of the gel 
bed was determined by filtration of 19S IgM, The open circles show the amount of 7S rabbit 
gamma globulin expressed as counts per second. Every second fraction was tested for mu and 
kappa structures by inhibition of passive hemagglutination. Small filled circles  (*), weak 
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mogenization of Prec, 2a liberated small amounts of mu structures which were 
only detectable in the supernatant (Sup. 2c) after concentration. 
When  the  various  fractions  were tested  for inhibition  of anti-kappa  anti- 
bodies  (Table II, right),  the inhibiting  material was found  to be distributed 
among the fractions similar to the mu structure.  In order to estimate the in- 
hibition of anti-kappa antibodies caused by IgM only, the smallest amount of 
Cell suspension 
1  Homogenate  ~ 
lOmin 
Prec. Io; 
^  .^  I  rehomogenized  200ug IL~  "~ 
Prec" Ib 1 
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105,000g 2hours  105,000g 2hours 
Prec. 2b j  k~,Prec. 20; 
rehomolgenized 
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~  Prec.2c 
Su ~.2b  Sup.2o  Sup. 2c 
FIG. 3. Homogenization and fractionation procedure of frozen and thawed leukemia cells. 
The precipitates were homogenized with the original volume of Tris buffer. 
19S IgM which inhibited the anti-kappa antibodies was divided by the calcu- 
lated amount of IgM in the various fractions. However, the titers calculated in 
this way (Table II) were invariably lower than the observed titers, indicating 
that the various fractions also contained kappa structures not  associated with 
IgM. This is in agreement with results presented above for Sup. 2a. 
After concentration,  Sup.  2a gave in gel diffusion tests a  distinct precipita- 
tion line with anti-kappa antibodies,  and a  faint line with anti-mu antibodies 
(Fig. 4). In contrast, the anti-mu reagent gave more distinct precipitation lines T.  ESKELAND~  E.  KLEIN~  M.  INOUE~  AND  B.  JOIIANSSON  273 
with  small amounts  of pure  7S  IgM  than  the  anti-kappa reagent.  This  also 
shows that there were more kappa than mu structures in Sup. 2a. 
After  concentration  and  density  gradient  ultracentrifugation  of  Sup.  2c, 
kappa and mu  structures were found in the levels of the tube  as already de- 
scribed for Sup. 2a. 
TABLE II 
The Amount  of Mu and Kappa Structures in  Various Cellular Fractions Determined by 
Inhibition of Passive Hemagglutination 
Anti-mu antibodies  Anti-kappa antibodies 
Sensitivity  Amount in  Sensitivity  Titer (cal- 
Titer  of test in  of test in  culated) if  Titer 
(observed)  #g of  /~g of  IgM/ml  IgM/rnl  /~g of  only IgM  (observed) 
IgM/rnl  was present 
Sensitivity 
of test in/Zg 
of kappa 
chains/ml 
Cell suspension  1/8  0.38  3.0  1.5  1/2  1/4 
(10%) 
Homogenate  1/8  3.0  1/2  1/4 
Prec.  la  1/2  <0.75  <1/1  1/1 
Sup. la  1/8  3.0  1/2  1/4 
Prec. lb  1/2  0.75  3.0  <1/1  1/1 
Sup. lb  1/1  0.38  <1/1  1/1 
1.5-0.75 
Prec. 2a  1/2  0.75  1.5  1.52  1/1  1/4 
Sup. 2a  1/2  1.5  1/1  1/2-1/4 
Prec. 2c  1/2  1.5  1/1  1/2 
Sup. 2c  <1.1  <0.75  <1/1  <1/1 
Prec. 2b  61/1  ~0.75  <1/1  <1/1 
Sup. 2b  <1/1  <0.75  <1/1  <1/1 
0.75 
Sup. 2c, conc.  1/4  0.75  3.0  3.0  1/1  1/2  1,5 
Sup. 2b, eonc.  1/1  0.75  <1/1  1/1 
Titer  (observed) shows the highest dilution of the fractions which completely inhibited 
passive hemagglutination with anti-mu or anti-kappa antibodies. Sensitivity of the test is the 
smallest amount of 19S IgM or free kappa chains giving complete inhibition. Amount of IgM 
is calculated from the titer (observed) and sensitivity of the test. Titer (calculated) gives an 
estimation of the inhibition of anti-kappa antibodies caused by IgM only. These titers were 
obtained by dividing the smallest amount of 19S IgM which inhibited anti-kappa antibodies 
(sensitivity of the test) by the calculated amount of IgM in the various fractions. 
Liberation of Mu and Kappa Structures by Freezing and Thawing.PFrozen and 
thawed  cells were  washed  twice with BSSg  and finally with Tris buffer.  The 
first two  washings were performed very  gently, while the third washing  was 
done as a homogenization. The supernatants obtained after the washings (Sup. A, 
Sup. B, and Sup. C)  were then run in the ultracentrifuge in order to sediment 
all membranes. By inhibition of passive hemagglutination it was found that a 
large proportion of the mu  and kappa structures  were  liberated as molecules 
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Liberation of Mu and Kappa Structures by Mercaptoethanol Treatment.--Before 
it became evident that homogenization released mu and kappa structures, viable 
cells were exposed to 2-mercaptoethaol. This treatment killed the cells. Material 
precipitated from the supernatant with ammonium sulphate was found to con- 
tain both mu and kappa structures.  By density gradient ultracentrifugation  of 
this material,  the mu structures were found to sediment somewhat slower than 
mu structures  liberated  by homogenization.  The position  of kappa  structures 
was not investigated. 
FIG. 4.  Double diffusion in agarose gel. Sup. 2a after concentration and various dilutions of 
7S Ig~V[  and kappa chains were tested against anti-mu and anti-kappa  antibodies. 
DISCUSSION 
The  Origin of the Isolated Immunoglobulin  Structures.--As  we  intended  to 
study mu and kappa structures made by small lymphocytes and found on the 
surface of the cells, it is,  of course, of the utmost importance to ascertain that 
the isolated  immunoglobulin  structures  were not directly derived  from an in- 
tracellular  pool or any exterior source. 
Three different approaches were used to exclude that significant amounts of 
immunoglobulins were directly derived from the interior of the cells. 
The first set of experiments included comparison of the staining of fixed and 
viable  cells  using  fluorescein-labeled  anti-mu  and  anti-kappa  antibodies.  The T.  ESKELAND,  E.  KLEIN,  M.  INOUE,  AND  B.  JOItANSSON  275 
fluorescence seemed to be localized solely on the cell membrane even in the case 
when fixed cells were stained  (1). Moreover, the inhibition  of the fluorescence 
staining  observed when viable  cells  were  exposed first to unconjugated  anti- 
bodies, and later to a fluorescein-labeled reagent, was equally effective as when 
viable cells were exposed to unconjugated antibodies,  followed by fixation and 
treatment with conjugated antibodies  (1). 
Secondly,  comparison  of the  absorbing  efficiency of viable  and  frozen  and 
thawed ceils showed that equal amounts of anti-kappa and anti-mu antibodies 
were removed by fixed numbers of cells (1). 
TABLE III 
Inhibition  of Passive  Hemagglutination  Used to Compare the Amount of Mu and  Kappa 
Structures  Liberated  as  Molecules  by  Two  Washings  (A  and  B)  Followed  by 
Homogenization  (C) of Frozen and  Thawed  Cells 
Anti-mu antibodies  Anti-kappa antibodies 
Dilution of the 
test material 
Cell  suspension 
Sup. A 
Sup. B 
Sup. C 
/1  1/2 
+  -- 
--  + 
+  ++ 
1/4 
++ 
++(+) 
1/8  1/16 
+-  ++ 
++(+)  +++ 
+++  +++ 
1/'32 
+ 
~-+(~ 
++4 
++4 
:/1  1/2 
-  + 
-  ++  (+: 
1/4  I/8 
++-~ +++ 
++-~ +++ 
1/16 
+(+) 
F+(+ 
+++ 
+++ 
1/32 
+++ 
+++ 
+++ 
+++ 
Beforo  testing, the supernatants wero run at 105,000 g for 2 hr. 
--, +-- Complete inhibition. 
+, +(+), ++  Some inhibition. 
++(+)  Weak, if any inhibition. 
+++  No inhibition. 
The third approach to exclude the presence of intracellular  immunoglobulin 
is described in this paper. The distribution of mu and kappa structures among 
various  fractions was investigated,  and no increase  of immunoglobulin  struc- 
tures during the fractionation procedure was found. About half the amount of 
immunoglobulin structures on the cells was liberated as isolated molecules. 
Blood cells absorb small quantities of plasma proteins, but it is not likely that 
we were dealing with proteins absorbed from the exterior. Only mu and kappa 
structures were found on the cells (6), and before homogenization the cells were 
extensively washed with BSS containing gelatin. 
Unfortunately the leukemia  cells have not been established  in culture.  But 
I)audi cells, derived from a Burkitt lymphoma and kept in culture for more than 
2 yr, carry mu and kappa structures  on the surface in similar amounts as the 
leukemia cells  (1,  3, 4).  This supports the assumption  that the leukemia cells 
synthesized their surface immunoglobulin structures. 
7S IgM and kappa chains constitute  only a  very minor fraction of the im- 
munoglobulins  in  serum  except  in  some patients  with  Waldenstr6m's  macro- 276  IG:V[ ON  LYMPHOID  CELLS 
globulinemia  (23)  or multiple myeloma. In  the  serum from patient T.P.  the 
immunoglobulin level was slightly subnormal (6),  and agarose electrophoresis 
revealed a normal immunoglobulin pattern (unpublished observation). It seems 
also pertinent  to mention that anti-mu and anti-kappa antibodies were cyto- 
toxic to these cells in the presence of complement (1). 
In conclusion,  no support has been found for the assumption that a signifi- 
cant  number  of immunoglobulin structures  liberated  from the  leukemia cells 
came from sources other than the cell surface. 
The Size of the Isolated Molecules.--The  analysis of molecular size included 
sucrose density gradient ultracentrifugation and gel filtration. As the mu and 
some of the kappa structures were found in the same fractions as the 7S rabbit 
gamma globulin, we suggest that 7S IgM is present and has a structure similar 
to that of 7S IgM from other sources. 
As mentioned  above,  7S  IgM  molecules constitute the subunit of 19S Ig2V[ 
molecules (9). 7S IgM also exists in cells secreting 19S IgM (12), and has been 
found in normal serum (10,  11) and in sara from patients with various diseases 
(23-28). 7S IgM serum seems to be secreted as 7S IgM molecules (29). 7S IgM 
molecules probably consist of two mu and two light chains, although the pres- 
ence of a third light chain has been suggested (30). 
In order to explain that  19S  IgM antibodies invariably are secreted earlier 
than IgG antibodies during an immune response, it has been proposed (31) that 
the IgM and IgG receptors on the immunocompetent cells are similar to the 
antibodies found in serum.  19S  IgM receptors should  be more effective than 
IgG receptors in binding antigens due to the higher number of combining sites, 
and  19S  IgM-producing cells would be more quickly  stimulated  to make an 
inunune  response. The finding that 7S  IgM was liberated from the surface of 
lymphoid cells indicates that the proposal just mentioned may be revised. 
The mu structures extracted from the cells by mercaptoethanol sedimented 
somewhat more slowly than the IgM extracted by homogenization. The reduc- 
tion in size was probably due to cleavage of chains or disulfide bonds (32-34). 
The free kappa structures found by ultracentrifugation  and gel filtration of 
various  supernatants  are  compatible  with  the  assumption  that  free  kappa 
chains were also present. Free kappa chains have previously been found in cells 
secreting immunoglobulins and in their secretion product  (35-37). 
The  Binding  Forces Keeping  the IgM  Molecules and  Kappa  Chains in  the 
Surface Membrane.--The liberations of 7S  IgM and  kappa  chains  were done 
under conditions not favorable for disruption of covalent bonds. On one occa- 
sion  an extract was prepared by homogenization  from living  cells in  one  se- 
quence at a  temperature near 0°C until a density gradient ultracentrifugation 
had  been  performed.  Examination  of  the  fractions  revealed  mu  and  kappa 
structures in the same levels of the tube as in the other experiments. 
Approximately half of the mu and kappa structures present on the cell surface 
could be isolated by homogenization of viable or frozen and thawed cells.  Even T.  ESKELAND,  E.  KLEIN, M.  INOUE,  AND  B.  JOtIANSSON  277 
careful washing of cells which had been frozen and thawed once was sufficient 
to liberate a large proportion of the molecules. In contrast, these cells had been 
washed  about  six  times  in  the  viable  state  during  their  purification.  This 
suggests that the binding of these molecules required an intact membrane. 
Some mu and kappa structures remained in the  membrane in spite of exten- 
sive homogenization. The forces keeping these structures in the membrane are 
presently under investigation. 
The Number of IgM Molecules and Kappa Chains on  the Cell Surface.--In 
the  following  calculations  it  will  be  assumed  that  all  the  immunoglobulin 
structures on the cell surface are similar to those liberated as isolated molecules 
by homogenization. 
It has previously been  shown  (1)  that  109  viable leukemia cells carry mu 
structures  on their  surface equivalent  to 25  /~g IgM. This value corresponds 
well with  the number obtained in the experiments reported here. A  10%  cell 
solution, containing about 2.5  )<  108 cells/ml, was shown to have 3/zg IgM/ml. 
It should  be pointed out  that  the latter value was obtained with  an inexact 
titration method only. For quantitations of this kind, the ideal situation is that 
the  antigen  used  for reference is physically identical  with  the  antigen  to be 
quantitated. This was obviously not possible to achieve. Since 7S and 19S IgM 
had similar inhibiting power on a weight basis, we assumed that 19S IgM could 
be used as a reference in our experiments. 
Assuming 25/zg IgM/109 cells and a molecular weight of 180,000,  80,000 7S 
IgM molecules have to be present on each cell. The local density of IgM mole- 
cules on the cell surface is difficult to estimate, since the fluorescence staining 
showed an uneven distribution of mu structures (1, 6). 
Inhibition of passive hemagglutination revealed that the cell suspension had a 
large excess of kappa structures as compared to mu structures (Table II). This 
was also found in the precipitates (Table II), and in Sup. 2a and Sup. 2c.  iso- 
lated kappa chains were demonstrated. 
The amount on the cell surface of kappa chains not forming a part of IgM 
can only be roughly calculated.  This is due to the fact that anti-kappa anti- 
bodies also were inhibited by IgM. Moreover, the finding that the inhibitory 
efficiency of kappa chains derived from 19S  IgM by reduction and alkylation 
was less than that of kappa chains in IgM suggests that kappa chains on the 
membranes and liberated chains behave differently in inhibition experiments. 
An estimation based on the  numbers in Table II gives the  results  that  the 
amount  of kappa chains  not  associated with  IgM  was  at  least  equal  to  the 
amount of kappa chains in IgM. 
SUMMARY 
Chronic lymphocytic leukemia cells with relatively large amounts of mu and 
kappa immunoglobulin  structures  on the  surface,  and  apparently very small 
amounts  intracellularly,  were  subjected  to  homogenization  or  washing  after 278  IGM  ON  LYMPHOID  CELLS 
freezing and thawing. After a light centrifugation, which sedimented the nuclei 
and unbroken cells, most of the immunoglobulin structures were found in the 
supernatant.  Ultracentrifugation,  which was performed  to remove  the  mem- 
branes from the supernatant,  sedimented only half the amount of the immuno- 
globulin structures. 
By sucrose density gradient  ultracentrifugation  and  Sephadex  G-200 filtra- 
tion, the unsedimented immunoglobulin structures were shown to consist of 7S 
IgM and free kappa chains. About 80,000 7S IgM molecules were calculated to 
be present  on each cell. The amount of kappa chains not associated with IgM 
was estimated to be equal to the amount of kappa chains in IgM. Inhibition of 
passive hemagglutination was used to detect and quantitate the immunoglobu- 
lin structures. 
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